Thrombolytic therapy with tissue plasminogen activator for superior vena cava thrombosis in an infant with sepsis
Özet
Superior vena cava syndrome is rare in infants, and rarely responds to conservative treatment. We report a 22-mo-old girl with superior vena cava syndrome due to the use of a central venous line and/or sepsis. Doppler study and computed tomography angiography of the neck showed thrombosis within the superior vena cava and jugular veins. She was admitted to a monitored setting and received recombinant tissue plasminogen activator for 2 d. The clinical features of superior vena cava syndrome disappeared completely 3 d after treatment. No complications were observed and radiological investigations showed blood flow through the thrombus after treatment.
Anahtar kelimeler
Atıf için künye
Tan, H., KIZILKAYA, M., Alper, F., Becit, N., & KÜRŞAT, H. (2005). Thrombolytic therapy with tissue plasminogen activator for superior vena cava thrombosis in an infant with sepsis. ACTA PAEDIATRICA, 94(2), 239–241. https://doi.org/10.1080/08035250410020163
BibTeX
@article{tan2005-223162,
author = {Tan, Hüseyin and KIZILKAYA, MEHMET and Alper, Fatih and Becit, Necip and KÜRŞAT, HÜSNÜ},
title = {Thrombolytic therapy with tissue plasminogen activator for superior vena cava thrombosis in an infant with sepsis},
journal = {ACTA PAEDIATRICA},
year = {2005},
volume = {94},
number = {2},
pages = {239--241},
issn = {0803-5253},
doi = {10.1080/08035250410020163},
url = {https://akademik.atauni.edu.tr/yayinlar/223162-thrombolytic-therapy-with-tissue-plasminogen-activator-for-superior-vena-cava}
}